These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 8182711
1. Synthesis and structure-activity relationships of deazaxanthines: analogs of potent A1- and A2-adenosine receptor antagonists. Grahner B, Winiwarter S, Lanzner W, Müller CE. J Med Chem; 1994 May 13; 37(10):1526-34. PubMed ID: 8182711 [Abstract] [Full Text] [Related]
2. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists. Hayallah AM, Sandoval-Ramírez J, Reith U, Schobert U, Preiss B, Schumacher B, Daly JW, Müller CE. J Med Chem; 2002 Mar 28; 45(7):1500-10. PubMed ID: 11906291 [Abstract] [Full Text] [Related]
3. Xanthines with C8 chiral substituents as potent and selective adenosine A1 antagonists. Peet NP, Lentz NL, Dudley MW, Ogden AM, McCarty DR, Racke MM. J Med Chem; 1993 Dec 10; 36(25):4015-20. PubMed ID: 8258823 [Abstract] [Full Text] [Related]
6. 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships. Stefanachi A, Nicolotti O, Leonetti F, Cellamare S, Campagna F, Loza MI, Brea JM, Mazza F, Gavuzzo E, Carotti A. Bioorg Med Chem; 2008 Nov 15; 16(22):9780-9. PubMed ID: 18938084 [Abstract] [Full Text] [Related]
7. Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions. Kim SA, Marshall MA, Melman N, Kim HS, Müller CE, Linden J, Jacobson KA. J Med Chem; 2002 May 23; 45(11):2131-8. PubMed ID: 12014951 [Abstract] [Full Text] [Related]
8. 8-Azaxanthine derivatives as antagonists of adenosine receptors. Franchetti P, Messini L, Cappellacci L, Grifantini M, Lucacchini A, Martini C, Senatore G. J Med Chem; 1994 Sep 02; 37(18):2970-5. PubMed ID: 8071944 [Abstract] [Full Text] [Related]
9. Effect of trifluoromethyl and other substituents on activity of xanthines at adenosine receptors. Jacobson KA, Shi D, Gallo-Rodriguez C, Manning M, Müller C, Daly JW, Neumeyer JL, Kiriasis L, Pfleiderer W. J Med Chem; 1993 Sep 03; 36(18):2639-44. PubMed ID: 8410976 [Abstract] [Full Text] [Related]
10. Aza-analogs of 8-styrylxanthines as A2A-adenosine receptor antagonists. Müller CE, Sauer R, Geis U, Frobenius W, Talik P, Pawlowski M. Arch Pharm (Weinheim); 1997 Jun 03; 330(6):181-9. PubMed ID: 9264243 [Abstract] [Full Text] [Related]
11. Synthesis and pharmacological evaluation of novel 1,3,8- and 1,3,7,8-substituted xanthines as adenosine receptor antagonists. Rodríguez-Borges JE, García-Mera X, Balo MC, Brea J, Caamaño O, Fernández F, López C, Loza MI, Nieto MI. Bioorg Med Chem; 2010 Mar 01; 18(5):2001-9. PubMed ID: 20137957 [Abstract] [Full Text] [Related]
12. Structure-activity relationships in a series of 8-substituted xanthines as A1-adenosine receptor antagonists. Strappaghetti G, Corsano S, Barbaro R, Giannaccini G, Betti L. Bioorg Med Chem; 2001 Mar 01; 9(3):575-83. PubMed ID: 11310591 [Abstract] [Full Text] [Related]
13. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists. Balo MC, Brea J, Caamaño O, Fernández F, García-Mera X, López C, Loza MI, Nieto MI, Rodríguez-Borges JE. Bioorg Med Chem; 2009 Sep 15; 17(18):6755-60. PubMed ID: 19682912 [Abstract] [Full Text] [Related]
14. Synthesis of paraxanthine analogs (1,7-disubstituted xanthines) and other xanthines unsubstituted at the 3-position: structure-activity relationships at adenosine receptors. Müller CE, Shi D, Manning M, Daly JW. J Med Chem; 1993 Oct 29; 36(22):3341-9. PubMed ID: 8230124 [Abstract] [Full Text] [Related]
15. Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl-8-[2-(5,6-epoxynorbonyl)]-xanthine. Pfister JR, Belardinelli L, Lee G, Lum RT, Milner P, Stanley WC, Linden J, Baker SP, Schreiner G. J Med Chem; 1997 Jun 06; 40(12):1773-8. PubMed ID: 9191953 [Abstract] [Full Text] [Related]
16. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists. Müller CE, Geis U, Grahner B, Lanzner W, Eger K. J Med Chem; 1996 Jun 21; 39(13):2482-91. PubMed ID: 8691445 [Abstract] [Full Text] [Related]
17. Synthesis and pharmacological evaluation of novel substituted 9-deazaxanthines as A2B receptor antagonists. Nieto MI, Balo MC, Brea J, Caamaño O, Fernández F, García-Mera X, López C, Loza MI, Rodríguez-Borges JE, Vidal B. Eur J Med Chem; 2010 Jul 21; 45(7):2884-92. PubMed ID: 20371139 [Abstract] [Full Text] [Related]
18. 1,3,7-Triethyl-substituted xanthines--possess nanomolar affinity for the adenosine A1 receptor. Van der Walt MM, Terre'Blanche G. Bioorg Med Chem; 2015 Oct 15; 23(20):6641-9. PubMed ID: 26392370 [Abstract] [Full Text] [Related]
19. Molecular simulation of 8-styrylxanthines. Mager PP, Reinhardt R, Richter M, Walther H, Rockel B. Drug Des Discov; 1995 Nov 15; 13(2):89-107. PubMed ID: 8872454 [Abstract] [Full Text] [Related]
20. 8-(Sulfostyryl)xanthines: water-soluble A2A-selective adenosine receptor antagonists. Müller CE, Sandoval-Ramírez J, Schobert U, Geis U, Frobenius W, Klotz KN. Bioorg Med Chem; 1998 Jun 15; 6(6):707-19. PubMed ID: 9681137 [Abstract] [Full Text] [Related] Page: [Next] [New Search]